Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults

NCT07331545 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Dysfunction-Associated Steatohepatitis(MASH)

Interventions

DRUG: QL2401
DRUG: Placebo

Sponsor

Qilu Pharmaceutical Co., Ltd.